Assessment of tissue characteristics

"Assessment of tissue characteristics" is not a therapeutic target or molecular receptor; rather, it refers to a diagnostic or clinical methodology used to evaluate the physical, chemical, and pathological properties of biological tissues. This phrase is most prominently associated with the ATLANTA (Assessment of Tissue characteristics, Lesion morphology, and hemodynamics by Angiography with fractional flow reserve, intravascular ultrasound and virtual histology, and noninvasive computed tomography in Atherosclerotic plaques) clinical trials, which focused on non-invasive and invasive imaging of coronary atherosclerotic plaques [3][6][10]. These assessments utilize various modalities such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Intravascular Ultrasound (IVUS) to characterize tissue features like fibrosis, lipid content, and inflammation [1][5][9]. In a research context, such assessments are critical for identifying biomarkers, stratifying patient risk, and monitoring therapeutic responses in diseases like atherosclerosis, cancer, and multi-organ fibrosis [1][2][14]. Consequently, while the term describes a crucial part of drug development and clinical practice, it does not represent a discrete protein or gene target.

Other names

ATLANTA studyClinical tissue characterizationDiagnostic tissue assessmentTissue phenotyping